Back to company

Pharma Components ApS: Financial statements 2022

CVR: 39103079

Pharma Components ApS (CVR 39103079) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 68,538 and a net result of DKK 57,077 compared with DKK -22,820 the year before. Equity amounted to DKK 49,378. The solvency ratio was 38.8%.

Gross Profit
68,538 kr.
Profit/Loss
57,077 kr.
Equity
49,378 kr.
Total Assets
127,287 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-69 t.57 t.49 t.0
2021--22 t.-23 t.-8 t.0
2020--17 t.-15 t.15 t.0
2019-45 t.35 t.31 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Pharma Components ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Pharma Components ApS: The 2021 annual report is outJun 1, 2022

Pharma Components ApS has published its annual report for 2021. Gross profit came to DKK -21,907, and the net result was DKK -22,820.

About Pharma Components ApS

Pharma Components ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named Pharma Components IVS. The management consists of Anders Fossing Riel. The company is owned by A.Rocket Holding ApS. In 2025, the company reported a gross profit of DKK -35,183 and a net result of DKK -115,173 compared with DKK 142,048 the year before. Equity amounted to DKK 272,393.

Other financial years